The HCPLive Rheumatology condition center page is a comprehensive resource for clinical news and insights on rheumatologic disease. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for arthritis, gout, nr-AxSpA, and more.
May 14th 2024
Data presented at NKF Spring Clinical Meeting suggest events including myocardial infarction and stroke are more prevalent among patients with lupus in North America.
Nurse Practitioner Q&A: Clues to Psoriatic Arthritis
September 9th 2019Psoriatic arthritis can manifest in a variety of ways from nail disease to peripheral joint pain. But, there are a few hallmark signs that can point a rheumatologist or rheumatology nurse in the right direction. In a presentation given at the Rheumatology Nurses Society annual meeting in August, Linda Grinnell-Merrick, NP, an allergy, immunology, and rheumatology nurse practitioner at the University of Rochester Medical Center, discussed the treatment of psoriatic arthritis.
Tips for Transitioning a Juvenile Idiopathic Arthritis Patient to Adult Care
September 9th 2019Better communication between pediatric and adult rheumatologists is especially important as pediatric patients with juvenile idiopathic arthritis transition to adult care. In this Q&A, we revisit a Rheumatology Nurses Society annual meeting presentation made last month by Cathy Patty-Resk, MSN, RN, CPNP, a pediatric rheumatology nurse practitioner with the Children’s Hospital of Michigan.
ACR’s Recommendations for Controlling Drug Costs, Improving Outcomes
September 5th 2019Affordability is a leading cause of drug abandonment among rheumatology patients. Back in April, the American College of Rheumatology issued a series of position statements designed to control drug costs while improving patient outcomes.
Incorporating the Pharmacist into the Rheumatology Practice
September 5th 2019Better treatment outcomes have been documented in studies when physicians and pharmacists work together. But it can be challenging, especially with changes in policies and procedures. In this article, Lisa Schwartz, PharmD., outlines the pros of teaming up.
Study Shows Benefits of Triple Therapy for RA
September 5th 2019Triple therapy and methotrexate‐based biologic disease‐modifying antirheumatic drug (DMARD) combinations were superior to methotrexate alone for both American College of Rheumatology (ACR50) response and remission in patients with rheumatoid arthritis, say researchers writing in Arthritis Research & Therapy last month.
Quiz: What is the best state to live in if you have rheumatoid arthritis?
September 5th 2019In this installment of our monthly rheumatoid arthritis quiz, we focus comorbidities associated with rheumatoid arthritis, adverse drug reactions and the best place to get care in the country. Learn more in this quiz.
Treatment Guidelines for Ankylosing Spondylitis and Non-Radiographic Axial Spondyloarthritis
September 5th 2019Updated treatment recommendations have been issued for ankylosing spondylitis and non-radiographic axial spondyloarthritis. There are 86 recommendations. In this slideshow, we highlight those categorized as "strongly recommended."
Potential New Lupus Treatment Passes Hurdle
August 31st 2019Anifrolumab, a potential new for lupus, just successfully completed a phase three clinical trial in which patients demonstrated reduced disease activity by significant margins, according to a statement issued by the drug’s maker AstraZeneca.
News Roundup from Rheumatology Network
August 30th 2019In this week's rheumatology news roundup, we feature a Q&A with Dr. Aryeh M. Abeles who talks with Rheumatology Network about his concerns with the black box warning label for the gout treatment febuxostat. We also include a story on addressing prescription abdandonment in rheumatoloyg. These and other stories in today's news roundup.
Introducing The Lancet Rheumatology
August 29th 2019This week, the British medical journal The Lancet, launched a new journal that focuses strictly on rheumatology. Aptly called "The Lancet Rheumatology," the journal's mission is to "provide an independent voice to the rheumatology community and to the millions of patients living with these conditions."
Black Box Blues for Gout Treatment Febuxostat
August 29th 2019Aryeh M. Abeles, M.D., talks with Rheumatology Network about the FDA's black box label for febuxostat, a gout treatment which, according to the results of one clinical trial, was shown to be associated with an increased risk of mortality. In this Q&A, Dr. Abeles, says the decision was based on flawed data.
Follow-ups may prevent prescription abandonment
August 27th 2019Nonadherence to a medication regimen is a problem in all of medicine, not just rheumatology. About 50 percent of all medications for chronic diseases are not taken as prescribed. Put another way, about two in every three Americans who have regular prescriptions aren’t taking them or aren’t taking them on schedule.
September is Rheumatic Disease Awareness Month
August 27th 2019September is more than back to school and the arrival of pumpkin-spice-flavored everything. It is also Rheumatic Disease Awareness Month, a national effort created by the American College of Rheumatology (ACR) in 2016 to bring attention to the more than 100 conditions that fall under the umbrella of rheumatic disease.
Early-Onset Gout May be Associated with Increased Cardiovascular Disease
August 27th 2019Patients diagnosed with gout at age 40 or younger may be at increased risk for cardiovascular disease and recurrent gout compared to those diagnosed later in life, according to a new study published in ACR Open Rheumatology.